IHS Chemical Week

World News and Views :: Projects

Lonza to Build Cell Therapy Production Facility in Singapore

10:23 AM MDT | May 22, 2009 | DEEPTI RAMESH

Lonza says it will build a cell therapy facility in Singapore to expand its global presence and meet growing worldwide demand. Lonza will invest SF30 million ($27 million) in the first construction phase of the plant, which will be located adjacent to Lonza’s large-scale mammalian cell culture facility at Tuas Biomedical Park. Construction is expected to begin in early 2010, with start up of two suites by mid-2011. Borgas: Cell therapy to become important innovation driver. The facility will be designed to accommodate additional suites to meet...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa